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Monday, February 27, 2012 353amyocytes (MCT 0.085 0.01 mm vs CON 0.045 0.01 mm, P < 0.001). MCT
n = 25 cells; CON n = 18 cells, 2 way RM ANOVA.
We conclude that the shorter resting SL in MCT myocytes is due to the forma-
tion of Ca2þ-independent cross-bridges, we speculate that these are formed in
response to disturbances in cellular metabolism, by mechanisms currently un-
der investigation.
Supported by the BHF and MRC
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Adult cardiac muscle adapts to changes in the environment by growth and
remodeling via a variety of mechanisms. Hypertrophy develops when the
heart is subjected to chronic mechanical overload. In ventricular pressure
overload (due to aortic stenosis) the heart typically reacts by concentric hy-
pertrophic growth, characterized by wall thickening due to myocyte thicken-
ing when sarcomeres are added in parallel. In ventricular volume overload,
an increase in filling pressure (due to mitral regurgitation) leads to eccentric
hypertrophy as myocytes grow axially by adding sarcomeres in series lead-
ing to ventricular cavity enlargement that is typically accompanied by some
wall thickening. The specific biomechanical stimuli that stimulate different
modes of hypertrophy are still poorly understood. Recently, we proposed
that cardiac myocytes grow longitudinally to maintain a preferred sarcomere
length in response to increased fiber strain and axially to maintain interfila-
ment lattice spacing in response to increased crossfiber strain. Here, we test
whether this growth law is able to predict concentric and eccentric hypertro-
phy in response to aortic stenosis and mitral valve regurgitation, respec-
tively, in a computational model of the adult canine heart coupled to
a closed loop model of circulatory hemodynamics. A finite element model
of the beating canine ventricles coupled to the circulation that was used. Af-
ter inducing valve alterations, the ventricles were allowed to adapt in shape
in response to mechanical stimuli over time. The proposed growth law was
able to reproduce major acute and chronic physiological responses when in-
tegrated with comprehensive models of the pressure- and volume-overloaded
canine heart, coupled to a closed-loop circulation. We conclude that strain-
based biomechanical stimuli consistent with in-vitro studies of myocyte
stretch responses can drive cardiac growth, including wall thickening during
pressure overload.
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Background: Hypertrophic cardiomyopathy (HCM) is frequently caused by
mutations in genes encoding sarcomeric proteins. Previously, we observed a re-
duced maximal force generating capacity (Fmax) of cardiomyocytes from
HCM patients with mutations in myosin-binding protein-C (MYBPC3). In
this study we investigated the contribution of myofibril density (MyoD) and
cross-sectional area (CSA) to the reduction in Fmax.
Methods: We measured Fmax and CSA of single permeabilized ventricular
cardiomyocytes of 27 HCM patients with mutations in MYBPC3, myosin
heavy chain: MYH7, troponin T: TNNT2 and troponin I: TNNI3 and 10
non-failing donor hearts. MyoD was calculated as the sum of myofibril area re-
lated to cell area assessed by electron microscopy.
Results: Average Fmax was significantly lower in HCM groups compared to
donor (Figure A). Figure B shows that MyoD of HCM hearts was reduced com-
pared to donors. CSA of HCM hearts (529548mm2) was significantly higher
compared to donors (342512mm2). Linear regression analysis revealed a
significant negative linear relationship between CSA and Fmax (R2= 0.50,
b=-0.023, p=0.014).Conclusion: Cardio-
myocyte hypertro-
phy and reduced
myofibrillar density
underlie depressed
Fmax in HCM with
mutations in thick
and thin sarcomeric
proteins.
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SPontaneous Oscillatory Contraction (SPOC) is a physiological state induced
in striated muscle fibres under conditions of partial activation. SPOC is charac-
terised by repetitive auto-oscillations between cycles of rapid lengthening and
slow shortening that correlate with diastole and systole respectively. We acti-
vate cardiomyocytes using ADP-induced SPOC and Ca2þ induced SPOC.
Ca-SPOC correlates well with heart rate observed in a number of animal
models.
The current study quantifies contractile performance of cardiomyocytes iso-
lated from human dilated and hypertrophic cardiomyopathies (some with
known mutations) and compares them with age-matched non-failing donors.
Measured parameters of contractile performance include the velocity, period
and amplitude of contraction, relaxation and SPOC-wave. We compare
changes in contractile performance between (1) failing and non-failing hearts,
(2) hearts from a wide range of donor ages, and (3) differences between ADP-
and Ca-SPOC. These observations are then related to patient clinical data (e.g.
ejection fraction).
Interestingly, human heart samples flash frozen (200C) within minutes of the
loss of coronary blood flow can be re-activated even after up to 20 years of stor-
age. Cardiac muscle fibres from the left atria and left ventricles, interventricular
septa and papillary muscles were specially defrosted prior to microdissection.
Length changes were measured using a Leica SP5 multi-photon microscope
and then averaged at high spatial and temporal resolution.
Preliminary data identify measureable changes in contractile performance be-
tween non-failing and failing hearts. Samples of hypertrophic cardiomyopathy
exhibit decreased rates of relaxation consistent with their clinical diagnosis.
These observations reveal SPOC to yield a range of functional parameters
that can be used to evaluate the functional state of human heart muscle fibres.
Thus, SPOC may prove to be a valuable measurement that can objectively as-
sess the state of human heart failure.
1794-Pos Board B564
Analyses of Sarcomeric Self-Oscillatory Properties of Rat Neonatal
Cardiomyocytes
Seine A. Shintani1, Mitsunori Yamane1, Kotaro Oyama1, Satoshi Kurihara2,
Shin’ichi Ishiwata1,3, Norio Fukuda2.
1Waseda Univ., Tokyo, Japan, 2Jikei Univ., Tokyo, Japan,
3Waseda Bioscience Research Institute in Singapore (WABIOS),
Singapore, Singapore.
It is generally believed that the rhythmof heartbeat is controlled by electric stim-
ulations produced by pacemaker cells. However, sarcomeres in cardiac myofi-
brils exhibit spontaneous rhythmic oscillations of sarcomere length (SL) and
force under partial activation conditions (i.e., SPOC). SPOC occurs either at
pCa~6.0 (Ca-SPOC ) or at the coexistence of MgADP and Pi in the absence of
Ca2þ (ADP-SPOC) (Ishiwata et al., 2011). We have reported that the SPOC pe-
riod correlates strongly with the resting heart rate in various animal species
(Sasaki et al., 2006). In the present study, to test whether SPOC plays a key
role in the regulation of heartbeat, we performed analyses on thewaveformprop-
erties of SPOC by using rat neonatal cardiomyocytes expressing AcGFP in the
Z-lines. First, we found that SPOC occurs in the neonatal myocytes treated
with ionomycin at pCa ~6.0 (pCa adjusted by Ca/EGTA), viz., in the presence
